These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34526531)

  • 41. Anti-tumor effects of canine adipose tissue-derived mesenchymal stromal cell-based interferon-β gene therapy and cisplatin in a mouse melanoma model.
    Seo KW; Lee HW; Oh YI; Ahn JO; Koh YR; Oh SH; Kang SK; Youn HY
    Cytotherapy; 2011 Sep; 13(8):944-55. PubMed ID: 21846298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-21-Expressing Mesenchymal Stem Cells Prevent Lethal B-Cell Lymphoma Through Efficient Delivery of IL-21, Which Redirects the Immune System to Target the Tumor.
    Kim N; Nam YS; Im KI; Lim JY; Lee ES; Jeon YW; Cho SG
    Stem Cells Dev; 2015 Dec; 24(23):2808-21. PubMed ID: 26415081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.
    Ling W; Zhang J; Yuan Z; Ren G; Zhang L; Chen X; Rabson AB; Roberts AI; Wang Y; Shi Y
    Cancer Res; 2014 Mar; 74(5):1576-87. PubMed ID: 24452999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor effect of cell therapy with mesenchymal stem cells on murine melanoma B16-F10.
    de Menezes FC; Cabral LGS; Petrellis MC; Neto CF; Maria DA
    Biomed Pharmacother; 2020 Aug; 128():110294. PubMed ID: 32485571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens.
    Zhao X; Bose A; Komita H; Taylor JL; Kawabe M; Chi N; Spokas L; Lowe DB; Goldbach C; Alber S; Watkins SC; Butterfield LH; Kalinski P; Kirkwood JM; Storkus WJ
    Mol Ther; 2011 Apr; 19(4):805-14. PubMed ID: 21189473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
    Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
    J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.
    Pulaski BA; Clements VK; Pipeling MR; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2000 Apr; 49(1):34-45. PubMed ID: 10782864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
    Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
    J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.
    Djouad F; Plence P; Bony C; Tropel P; Apparailly F; Sany J; Noël D; Jorgensen C
    Blood; 2003 Nov; 102(10):3837-44. PubMed ID: 12881305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity.
    Kudo-Saito C; Fuwa T; Kawakami Y
    Eur J Cancer; 2016 Jul; 62():54-61. PubMed ID: 27208904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of interleukin 12 to antitumor cytokine and gene therapy.
    Nishimura T; Watanabe K; Yahata T; Ushaku L; Ando K; Kimura M; Saiki I; Uede T; Habu S
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S27-34. PubMed ID: 8765412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
    Lucas ML; Heller R
    DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment.
    François S; Usunier B; Forgue-Lafitte ME; L'Homme B; Benderitter M; Douay L; Gorin NC; Larsen AK; Chapel A
    Stem Cells Transl Med; 2019 Mar; 8(3):285-300. PubMed ID: 30451398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells.
    Iida Y; Yoshikawa R; Murata A; Kotani H; Kazuki Y; Oshimura M; Matsuzaki Y; Harada M
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Notch1-WISP-1 axis determines the regulatory role of mesenchymal stem cell-derived stromal fibroblasts in melanoma metastasis.
    Shao H; Cai L; Moller M; Issac B; Zhang L; Owyong M; Moscowitz AE; Vazquez-Padron R; Radtke F; Liu ZJ
    Oncotarget; 2016 Nov; 7(48):79262-79273. PubMed ID: 27813493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.
    Bozeman EN; Cimino-Mathews A; Machiah DK; Patel JM; Krishnamoorthy A; Tien L; Shashidharamurthy R; Selvaraj P
    Vaccine; 2013 May; 31(20):2449-56. PubMed ID: 23541884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.